| Filed On | Filing |
|---|---|
| 10 Sep 2026 |
8-K/A: Entry into a Material Definitive Agreement; Regulation FD Disclosure
This AGREEMENT AND PLAN OF MERGER (this “Agreement”), dated as of September 9, 2026, is entered into by and among Axogen, Inc., a Minnesota corporation (“Buyer”), Omega Merger Sub, Inc., a Georgia corporation and a wholly-owned subsidiar... |
| 10 Jun 2024 |
8-K/A: Submission of Matters to a Vote of Security Holders
On June 5, 2024, the Company held the Annual Meeting, at which a total of 36,494,777 shares of common stock of the Company, out of a total 43,704,574 shares of common stock outstanding and entitled to vote as of April 19, 2024, the recor... |
| 05 Jan 2024 |
8-K/A: Departure/Election of Directors or Officers; Compensation
Execution Copy ny-2653039.8 SEPARATION, WAIVER AND RELEASE OF CLAIMS AGREEMENT This Confidential Separation, Waiver and Release of Claims Agreement and Exhibits hereto (“Separation Agreement”), by and between Axogen Corporation (“Axogen”... |
| 06 Jun 2018 |
8-K/A: Submission of Matters to a Vote of Security Holders
On May 14, 2018, the Company held its 2018 Annual Meeting of Shareholders (the “Annual Meeting”) to act upon the matters described in the Company’s 2018 Proxy Statement dated March 30, 2018 (the “Proxy Statement”). Of the 34,560,243 shar... |
| 20 Jul 2017 |
8-K/A: Departure/Election of Directors or Officers; Compensation
THIS EXECUTIVE EMPLOYMENT AGREEMENT (the "Agreement"), effective as of July 17, 2017, is made by and between AXOGEN CORPORATION, a Delaware corporation ("AXOGEN" or "Employer"), and Jon S. Gingrich ("Employee") (collectively, the "Partie... |
| 04 Feb 2015 |
8-K/A: Financial Statements and Exhibits
Pursuant to 17 CFR 240.24b-2, confidential information has been omitted in places marked “[***]” and has been filed separately with the Securities and Exchange Commission pursuant to a Confidential Treatment Application filed with the Co... |
| 25 Jan 2012 |
8-K/A: Financial Statements and Exhibits
CONFIDENTIAL TREATMENT REQUESTED UNDER 17 C.F.R. §§ 200.80(B)(4) AND 230.406. THE CONFIDENTIAL PORTIONS OF THIS EXHIBIT HAVE BEEN OMITTED AND ARE MARKED ACCORDINGLY. THE CONFIDENTIAL PORTIONS HAVE BEEN FILED SEPARATELY WITH THE SECURITIE... |
| 14 Nov 2011 |
8-K/A: Changes in Registrant's Certifying Accountant
We have been furnished with a copy of the response to Item 4.01 of Form 8-K/A for the event that occurred on September 30, 2011, to be filed by AxoGen, Inc., the parent company of our former client, AxoGen Corporation. We agree with the ... |
Loading...